INTRODUCTION AND OBJECTIVES:
Much research has focused on the pathophysiology of urinary tract infections (UTIs). However, insight into patient perspective and impact of recurrent UTIs (rUTIs) on quality of life (QoL) is sparse. The objective of this study was to identify discrepancies in patient and physician perspectives of care provided to patients with rUTIs with the hope of improving the quality of care.
METHODS: Patient perspectives were obtained by recruiting women with rUTIs (n[29) to small focus group discussions regarding knowledge, prevention strategies, treatment with antibiotics and alternatives, and impact on QoL. Physician perspectives were obtained, blinded to focus group discussion results, through interviews with experts specializing in UTI management. Qualitative analysis was performed using grounded theory methods as described by Charmaz. Themes developed by independent coders were compared and contrasted.
RESULTS: Analysis of transcripts produced three predominant themes. First, patients were fearful of undertreated acute infections due to miscommunication with primary care providers, adverse effects from antibiotic usage, and rUTIs as a harbinger of larger underlying disease. Physicians also noted patient fear associated with rUTI; they augmented rUTI management with imaging and procedures to evaluate for undiagnosed morbidities associated with UTIs and engaged in extensive counseling. Second, while patients with rUTIs were more focused on improving care for acute UTIs, physicians were conversely more focused on prophylaxis and efficacious management of a chronic condition. Third, while patients reported resentment and frustration with the management of both their acute and rUTIs, physicians paradoxically believed that their patients were overall satisfied with their care.
CONCLUSIONS: Patient focus group discussions and physician interviews demonstrated the importance of addressing patient fear of rUTIs through specialty diagnostics and counseling by experts. Referral to UTI specialist allowed for more detailed evaluation of a patient's history of bladder, bowel, and pelvic floor dysfunction; attention to antibiotic stewardship; and shared decision making. Analysis revealed that patients focus more on acute infections, while expert physicians focus on the chronic condition. This may explain the discrepancy in perceived satisfaction between the patient and treating physicians and highlight the need to improve current UTI management through patient education and expected treatment outcomes. The objective of the study is to provide further evidence supporting the effectiveness of RAPN in tertiary care centers and to describe the evolution of RAPN based technical improvements.
METHODS: The Transatlantic Robotic Nephron-sparing Surgery (TRoNeS) study group prospectively collected data from 635 patients subjected to RAPN between 2010 and 2016 at three high volume tertiary care centers. All patients underwent either preoperative CT-scan or MRI to anatomically define the renal masses.
RESULTS: Of 635 patients, 399 (62.8%) were males. Mean patient age was 60.7 yrs and mean preoperative tumor size was 33 mm, with 324 (51.0%) of tumors being right sided. According to the PADUA score, 202 (31.8%) patients had a low complexity tumor, while 235 (37.0%) and 198 (31.2%) were of intermediate and high complexity, respectively.
In the majority of patients, a transperitoneal approach was used (n[447; 70.4%). Mean operative time was 156.3 minutes and mean estimated blood loss was 171 mL. Main artery clamping was performed in 506 (79.7%) patients, as compared to 107 (16.9%) undergoing selective clamping and 22 (3.4%) individuals were a "zero-ischemia" RAPN was performed. Mean WIT was 16.3 minutes; 141 (22.2%) patients experienced a WIT >20 minutes.
Malignant tumors were observed in 473 (74.5%) individuals and surgical margins were positive in 24 (3.8%) patients. Overall, 25 (3.9%) patients experienced a significant (Clavien-Dindo >2) complication. No statistically significant differences between preoperative and postoperative creatinine values were observed (p[0.823). Optimal surgical outcomes defined according to the MIC score were achieved in 459 (72.3%) individuals. At a mean follow-up of 26 months, 2 local and 2 distant recurrences of the disease were observed.
Finally, in multivariable LRMs patients with highly complex tumors according to the PADUA score experienced a 3.2-fold higher risk of not achieving optimal surgical outcomes relative to patients with lowcomplexity tumors (p[0.001) CONCLUSIONS: The current study provides further evidences supporting the role of RAPN as a viable and effective minimally-invasive alternative to OPN in the treatment of clinically-localized renal tumors. Despite surgical experience and technological improvements, tumor complexity still represents an independent predictor of optimal surgical outcomes.
